270 related articles for article (PubMed ID: 24286642)
21. miRNAs in breast cancer: ready for real time?
Krell J; Frampton AE; Jacob J; Castellano L; Stebbing J
Pharmacogenomics; 2012 Apr; 13(6):709-19. PubMed ID: 22515613
[TBL] [Abstract][Full Text] [Related]
22. Age-related microRNAs in older breast cancer patients: biomarker potential and evolution during adjuvant chemotherapy.
Dalmasso B; Hatse S; Brouwers B; Laenen A; Berben L; Kenis C; Smeets A; Neven P; Schöffski P; Wildiers H
BMC Cancer; 2018 Oct; 18(1):1014. PubMed ID: 30348127
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
Rodríguez Bautista R; Ortega Gómez A; Hidalgo Miranda A; Zentella Dehesa A; Villarreal-Garza C; Ávila-Moreno F; Arrieta O
Clin Epigenetics; 2018; 10():88. PubMed ID: 29983835
[TBL] [Abstract][Full Text] [Related]
24. The Role of MicroRNA as Clinical Biomarkers for Breast Cancer Surgery and Treatment.
Davey MG; Davies M; Lowery AJ; Miller N; Kerin MJ
Int J Mol Sci; 2021 Aug; 22(15):. PubMed ID: 34361056
[TBL] [Abstract][Full Text] [Related]
25. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
[TBL] [Abstract][Full Text] [Related]
26. MicroRNAs in breast cancer: New maestros defining the melody.
Khalife H; Skafi N; Fayyad-Kazan M; Badran B
Cancer Genet; 2020 Aug; 246-247():18-40. PubMed ID: 32805688
[TBL] [Abstract][Full Text] [Related]
27. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
[TBL] [Abstract][Full Text] [Related]
28. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
[TBL] [Abstract][Full Text] [Related]
29. Circulating microRNAs as noninvasive biomarkers in breast cancer.
Cortez MA; Welsh JW; Calin GA
Recent Results Cancer Res; 2012; 195():151-61. PubMed ID: 22527502
[TBL] [Abstract][Full Text] [Related]
30. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
[TBL] [Abstract][Full Text] [Related]
31. Breast Cancer Response to Therapy: Can microRNAs Lead the Way?
Petrović N; Nakashidze I; Nedeljković M
J Mammary Gland Biol Neoplasia; 2021 Jun; 26(2):157-178. PubMed ID: 33479880
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA analysis of NCI-60 human cancer cells indicates that miR-720 and miR-887 are potential therapeutic biomarkers for breast cancer.
Lv Z; Wang S; Zhao W; He N
Drug Discov Ther; 2020 Sep; 14(4):197-203. PubMed ID: 32863323
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA Expression Profiles and Breast Cancer Chemotherapy.
Davey MG; Lowery AJ; Miller N; Kerin MJ
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639152
[TBL] [Abstract][Full Text] [Related]
34. Oncogenesis and Tumor Inhibition by MicroRNAs and its Potential Therapeutic Applications: A Systematic Review.
Karkhane M; Lashgarian HE; Hormozi M; Fallahi S; Cheraghipour K; Marzban A
Microrna; 2020; 9(3):198-215. PubMed ID: 31686643
[TBL] [Abstract][Full Text] [Related]
35. microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer.
Goh JN; Loo SY; Datta A; Siveen KS; Yap WN; Cai W; Shin EM; Wang C; Kim JE; Chan M; Dharmarajan AM; Lee AS; Lobie PE; Yap CT; Kumar AP
Biol Rev Camb Philos Soc; 2016 May; 91(2):409-28. PubMed ID: 25631495
[TBL] [Abstract][Full Text] [Related]
36. Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability.
Naser Al Deen N; Nassar F; Nasr R; Talhouk R
Adv Exp Med Biol; 2019; 1152():335-364. PubMed ID: 31456193
[TBL] [Abstract][Full Text] [Related]
37. Serum microRNA-21 expression as a prognostic and therapeutic biomarker for breast cancer patients.
Yadav P; Mirza M; Nandi K; Jain SK; Kaza RC; Khurana N; Ray PC; Saxena A
Tumour Biol; 2016 Nov; 37(11):15275-15282. PubMed ID: 27696295
[TBL] [Abstract][Full Text] [Related]
38. [The Role of MicroRNAs in Colorectal Cancer].
Kim SW
Korean J Gastroenterol; 2017 Apr; 69(4):206-211. PubMed ID: 28449421
[TBL] [Abstract][Full Text] [Related]
39. The network of non-coding RNAs and their molecular targets in breast cancer.
Crudele F; Bianchi N; Reali E; Galasso M; Agnoletto C; Volinia S
Mol Cancer; 2020 Mar; 19(1):61. PubMed ID: 32188472
[TBL] [Abstract][Full Text] [Related]
40. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
